Browse Title Index
| Issue | Title | |
| Vol 9, No 4 (2013) | Słowo redakcyjne | Details PDF (Polish) |
| Marek Pawlicki | ||
| Vol 7, Supp. C (2011) | Słowo Wstępne | Abstract PDF (Polish) |
| Maciej Krzakowski | ||
| Vol 7, Supp. C (2011) | Słowo Wstępne | Abstract PDF (Polish) |
| Piotr Wysocki, Jakub Żołnierek | ||
| Vol 10, Supp. A (2014) | Słowo wstępne | Details PDF (Polish) |
| Maciej Krzakowski, Piotr J. Wysocki | ||
| Vol 7 (2011): Special issue | Tajemnica lekarska okiem lekarza - Karoliny Pyziak-Kowalskiej oraz prawnika Pawła Kowalskiego | Details PDF (Polish) |
| Karolina Pyziak-Kowalska, Paweł Kowalski | ||
| Vol 3, No 3 (2007) | Targeted therapy - the new hopes in breast cancer treatment | Abstract PDF (Polish) |
| Renata Duchnowska | ||
| Vol 18, No 3 (2022) | Targeted therapy for advanced cutaneous melanoma | Abstract PDF HTML |
| Alice Indini, Fausto Roila, Rossana Gueli, Francesco Grossi, Mario Mandalà | ||
| Vol 3, No 6 (2007) | Targeted therapy of colorectal cancer patients | Abstract PDF (Polish) |
| Marek Z. Wojtukiewicz, Ewa Sierko | ||
| Vol 5, No 6 (2009) | Targeted therapy of hepatocellular carcinoma with sorafenib. Finally a breakthrough or maybe just the beginning of a long way? | Abstract PDF (Polish) |
| Piotr Potemski | ||
| Vol 6 (2010): Special issue | Tego nauczył mnie prof. Koszarowski: onkologia nie jest nauką o nowotworach, ale o leczeniu ludzi chorych na nowotwory | Details PDF (Polish) |
| Janusz Meder | ||
| Vol 5, Supp. C (2009) | Temyrolimus w leczeniu zaawansowanego raka nerwowokomórkowego | Abstract PDF (Polish) |
| pod red. Macieja Krzakowskiego | ||
| Vol 7, Supp. C (2011) | Terapia chorej na raka jasnokomórkowego nerki lekami ukierunkowanymi molekularnie | Abstract PDF (Polish) |
| Lubomir Bodnar | ||
| Vol 12, No 5 (2016) | The activity of pembrolizumab in therapy of pretreated metastatic melanomas — two centres’ experience | Abstract PDF |
| Paweł Rogala, Joanna Stępniak, Tomasz Świtaj, Ewa Kalinka-Warzocha, Katarzyna Kozak, Hanna Koseła-Paterczyk, Piotr Rutkowski | ||
| Vol 11, No 1 (2015) | The algorithm assessing the value of new anticancer drugs — the proposal of the Polish Society of Clinical Oncology and Polish Oncological Society | Abstract PDF (Polish) HTML (Polish) |
| Maciej Krzakowski, Piotr Wysocki, Jacek Jassem, Krzysztof Krzemieniecki, Piotr Potemski, Rafał Zyśk | ||
| Vol 5, Supp. A (2009) | The approach to antiangiogenic therapy in cancer patients | Abstract PDF (Polish) |
| Marek Z. Wojtukiewicz, Ewa Sierko | ||
| Vol 1, No 1 (2005) | The colony stimulating factors for the management of chemotherapy-induced neutropenia | Abstract PDF (Polish) |
| David C. Dale | ||
| Vol 4, No 2 (2008) | The concept of breast surgeon according to European Society of Mastology | Abstract PDF (Polish) |
| Agnieszka Kołacińska | ||
| Vol 20, No 2 (2024) | The effect of different concentrations of anti-PD-1 and anti-PD-L1 antibodies on the activity of immune system cells in patients with non-small cell lung cancer | Abstract PDF HTML |
| Aleksandra Bożyk, Kamila Wojas-Krawczyk, Marcin Nicoś, Paweł Krawczyk | ||
| Vol 17, No 5 (2021) | The effect of education training intervention on the caregiver burden among mothers of children with leukemia: a quasi-experimental study | Abstract PDF |
| Hossein Karimjejad, Fereshteh Ghaljaei, Fatemeh Kiani | ||
| Vol 19, No 5 (2023) | The effect of spirituality-based education on the meaning of life in cancer patients: a quasi-experimental study | Abstract PDF HTML |
| Sajad Hamidi, Naima Seyedfatemi, Marjan Mardani-Hamooleh, Zahra Abbasi, Hadi Hamidi | ||
| Vol 15, No 2 (2019) | The effectiveness of chemotherapy in small cell lung cancer patients with BRCA2 gene mutation and Schwartz-Bartter syndrome | Abstract PDF |
| Małgorzata Flis, Paweł Krawczyk, Izabella Drogoń, Katarzyna Kurek, Robert Kieszko, Janusz Milanowski | ||
| Vol 11, No 5 (2015) | The efficacy and safety of ipilimumab in patients with advanced cutaneous or mucosal melanoma | Abstract PDF HTML |
| Hanna Koseła-Paterczyk, Maja Wasylecka-Morawiec, Katarzyna Kozak, Beata Jagielska, Tomasz Świtaj, Piotr Rutkowski | ||
| Vol 10, No 4 (2014) | The efficacy and safety of vemurafenib in therapy of patients with unresectable cutaneous melanoma in the light of updated results of BRIM-3 trial | Abstract PDF (Polish) |
| Katarzyna Kozak, Piotr Rutkowski | ||
| Vol 16, No 1 (2020) | The evolution of biologics in the context of oncological therapy | Abstract PDF |
| Bartłomiej Żerek, Wojciech Straś, Piotr Rózga, Elżbieta Pękala | ||
| Vol 8, No 3 (2012) | The gastrointestinal and hepatic lapatinib-associated adverse effects | Abstract PDF |
| Aleksandra Łacko | ||
| 1001 - 1025 of 1173 Items | << < 36 37 38 39 40 41 42 43 44 45 > >> | |